Sherree Smith, DPM
Podiatrist · Plymouth, MANPI 1801848163
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $667, 4.7 times the $141 reported in 2019.
Across 83 payments — averaging $22.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$293
- Amgen$220
- Paratek Pharmaceuticals, Inc.$189
- ANI Pharmaceuticals, Inc.$176
- Orthofix Medical, Inc.$165
- Bioventus LLC$139
- plus $691 from 17 others
What the payments were for
- Food & beverage$1,872100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 10 | $293 |
| Amgen(2 entities) | 12 | $220 |
| Paratek Pharmaceuticals, Inc. | 8 | $189 |
| ANI Pharmaceuticals, Inc. | 7 | $176 |
| Orthofix Medical, Inc. | 7 | $165 |
| Bioventus LLC | 5 | $139 |
| Organogenesis Inc. | 5 | $114 |
| Smith+Nephew | 5 | $95 |
| Boston Scientific | 2 | $51 |
| Alfasigma USA, Inc. | 2 | $44 |
| Solventum Corporation | 2 | $44 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $42 |
| Zimmer Biomet | 1 | $41 |
| Integra Lifesciences Corporation | 2 | $40 |
| Polynovo North America LLC | 2 | $40 |
| Advanced Oxygen Therapy Inc. | 3 | $32 |
| Misonix Inc | 1 | $29 |
| Merck | 2 | $28 |
| Medshape, Inc. | 1 | $27 |
| Convatec Inc. | 1 | $21 |
| GRT US Holding, Inc. | 1 | $18 |
| DJO, LLC | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $13 |
How this compares
$1,872 in reported general payments places this provider in the 70th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 63 | $1,290 |
| Ammonium Lactate | 43 | $840 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 40 | $606 |
| Terbinafine Hcl | 39 | $333 |
| Meloxicam | 82 | $211 |
| Nystatin | 15 | $171 |
| Cephalexin | 34 | $119 |
| Methylprednisolone | 14 | $117 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $87 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Plymouth
- David CokerPlymouth$6K
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Jonathan KaplanWellesley$56K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
- Louis DecaroWest Hatfield$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.